There are 2789 resources available
1633P - Why do cancer clinical trials (CT) discontinue prematurely in the era of COVID-19?
Presenter: Giovanni Maria Iannantuono
Session: ePoster Display
1634P - Communication specifics with cancer patients during the COVID-19 pandemic in Croatia: Can a virtual visit meet the needs of cancer patients?
Presenter: Renata Kelemenic-Drazin
Session: ePoster Display
1635P - Impact of the COVID-19 pandemic on cancer care in Tunisia: Oncologists' perception
Presenter: Ichrak Ben Abdallah
Session: ePoster Display
1636P - Health behavior of cancer patients during COVID-19 pandemic. Focus head neck cancer
Presenter: Judith Büntzel
Session: ePoster Display
1637P - Unintended consequences for an integrated oncology ecosystem from COVID adaptations
Presenter: Philip Bredin
Session: ePoster Display
1638P - Experience with telemedicine during COVID-19 pandemic
Presenter: Sandra Soriano
Session: ePoster Display
1639P - Impact of COVID-19 on ongoing oncological and hematological treatment strategy
Presenter: Arnaud Bayle
Session: ePoster Display
1529P - Treatment results in elderly patients (pts) diagnosed with locally advanced soft tissue sarcoma (STS)
Presenter: Hanna Kosela Paterczyk
Session: ePoster Display
1651P - Phase I study of ramucirumab in combination with irinotecan plus cisplatin in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)
Presenter: Toshiaki Takahashi
Session: ePoster Display
1652P - Safety of simultaneously performed radiotherapy in patients with small cell lung cancer undergoing atezolizumab treatment
Presenter: Julia Galuba
Session: ePoster Display